Using advanced MRI techniques to improve management of renal cancer and kidney function
Advanced Diffusion Imaging for Management of Renal Cancer: Oncologic Control and Renal Functional Reserve - Resubmission - 1
This study is looking at new MRI techniques to help doctors understand how kidney cancer affects kidney function and to see how surgery might help, so patients can get better care before and after their treatment.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | New York University School of Medicine NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-11078806 on NIH RePORTER |
What this research studies
This research focuses on developing advanced diffusion-weighted MRI techniques to monitor renal function in patients with renal cancer. It aims to noninvasively assess the aggressiveness of tumors and predict the impact of surgical interventions on kidney function. By utilizing innovative imaging methods, the study seeks to provide better insights into the health of the kidneys before and after surgery, potentially improving patient outcomes. Patients will undergo MRI scans to evaluate their condition and track changes over time.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients diagnosed with renal cancer who are scheduled for surgical intervention.
Not a fit: Patients with renal cancer who are not candidates for surgery or those with advanced kidney disease may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved management strategies for renal cancer patients, helping to preserve kidney function and reduce the risk of chronic kidney disease.
How similar studies have performed: Previous research has shown promise in using advanced MRI techniques for cancer assessment, indicating potential success for this novel approach.
Where this research is happening
New York, United States
- New York University School of Medicine — New York, United States (Active)
Researchers
- Principal investigator: Sigmund, Eric Edward — New York University School of Medicine
- Study coordinator: Sigmund, Eric Edward
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.